SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001372514-24-000013
Filing Date
2024-02-12
Accepted
2024-02-12 17:23:39
Documents
58
Period of Report
2024-02-12
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K kprx-20240212.htm   iXBRL 8-K 26142
2 EX-99.1 kiorapharmaoverviewh1202.htm EX-99.1 38394
6 kiorapharmaoverviewh1202001.jpg GRAPHIC 45042
7 kiorapharmaoverviewh1202002.jpg GRAPHIC 184697
8 kiorapharmaoverviewh1202003.jpg GRAPHIC 71828
9 kiorapharmaoverviewh1202004.jpg GRAPHIC 68344
10 kiorapharmaoverviewh1202005.jpg GRAPHIC 66725
11 kiorapharmaoverviewh1202006.jpg GRAPHIC 78148
12 kiorapharmaoverviewh1202007.jpg GRAPHIC 89921
13 kiorapharmaoverviewh1202008.jpg GRAPHIC 81189
14 kiorapharmaoverviewh1202009.jpg GRAPHIC 37993
15 kiorapharmaoverviewh1202010.jpg GRAPHIC 85061
16 kiorapharmaoverviewh1202011.jpg GRAPHIC 87982
17 kiorapharmaoverviewh1202012.jpg GRAPHIC 86077
18 kiorapharmaoverviewh1202013.jpg GRAPHIC 87325
19 kiorapharmaoverviewh1202014.jpg GRAPHIC 91987
20 kiorapharmaoverviewh1202015.jpg GRAPHIC 79267
21 kiorapharmaoverviewh1202016.jpg GRAPHIC 116144
22 kiorapharmaoverviewh1202017.jpg GRAPHIC 93016
23 kiorapharmaoverviewh1202018.jpg GRAPHIC 65744
24 kiorapharmaoverviewh1202019.jpg GRAPHIC 93980
25 kiorapharmaoverviewh1202020.jpg GRAPHIC 73031
26 kiorapharmaoverviewh1202021.jpg GRAPHIC 82318
27 kiorapharmaoverviewh1202022.jpg GRAPHIC 92086
28 kiorapharmaoverviewh1202023.jpg GRAPHIC 92353
29 kiorapharmaoverviewh1202024.jpg GRAPHIC 71190
30 kiorapharmaoverviewh1202025.jpg GRAPHIC 83982
31 kiorapharmaoverviewh1202026.jpg GRAPHIC 64373
32 kiorapharmaoverviewh1202027.jpg GRAPHIC 125095
33 kiorapharmaoverviewh1202028.jpg GRAPHIC 94798
34 kiorapharmaoverviewh1202029.jpg GRAPHIC 81768
35 kiorapharmaoverviewh1202030.jpg GRAPHIC 87823
36 kiorapharmaoverviewh1202031.jpg GRAPHIC 79698
37 kiorapharmaoverviewh1202032.jpg GRAPHIC 37078
38 kiorapharmaoverviewh1202033.jpg GRAPHIC 77376
39 kiorapharmaoverviewh1202034.jpg GRAPHIC 99957
40 kiorapharmaoverviewh1202035.jpg GRAPHIC 74902
41 kiorapharmaoverviewh1202036.jpg GRAPHIC 111582
42 kiorapharmaoverviewh1202037.jpg GRAPHIC 62300
43 kiorapharmaoverviewh1202038.jpg GRAPHIC 32972
44 kiorapharmaoverviewh1202039.jpg GRAPHIC 90353
45 kiorapharmaoverviewh1202040.jpg GRAPHIC 88056
46 kiorapharmaoverviewh1202041.jpg GRAPHIC 75441
47 kiorapharmaoverviewh1202042.jpg GRAPHIC 52518
48 kiorapharmaoverviewh1202043.jpg GRAPHIC 32768
  Complete submission text file 0001372514-24-000013.txt   4998254

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT kprx-20240212.xsd EX-101.SCH 1919
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT kprx-20240212_lab.xml EX-101.LAB 24851
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT kprx-20240212_pre.xml EX-101.PRE 13058
59 EXTRACTED XBRL INSTANCE DOCUMENT kprx-20240212_htm.xml XML 2814
Mailing Address 332 ENCINITAS BOULEVARD SUITE 102 ENCINITAS CA 92024
Business Address 332 ENCINITAS BOULEVARD SUITE 102 ENCINITAS CA 92024 781-788-8869
KIORA PHARMACEUTICALS INC (Filer) CIK: 0001372514 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36672 | Film No.: 24621373
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)